Thursday, July 29

Spain exceeds 500 cases of incidence rate for the first time since February

The cumulative incidence continues to rise in Spain. This Thursday it stands at 500 cases per 100,000 inhabitants in the last 14 days, which translates into 31 points more than the day before, when it was 469. It is the highest figure since February 11. The data continues to be worrying among young people: in the population aged 12 to 19 it is 1,311.73 points, for those who go from 20 to 29, it is 1,581.39 and finally, in the range of 30 to 39, it is at 658.96 points.

All in a day in which Health has added 27,688 new infections. In total, since the beginning of the pandemic, 4,069,162 people confirmed by test have been infected in Spain.

Regarding the deceased, the authorities have added 41 new ones, bringing the total since March 2020 to 81,084. Of them, 49 have died in the last seven days.

The total of those immunized with the complete regimen in Spain exceeds 48%

Spain reached 48.4% of the population vaccinated with the full schedule this Thursday. That is, 22,949,155 people have received two doses of Pfizer, Moderna or AstraZeneca or one of Janssen – the only antidote that comes with a single puncture.

In addition, more than 28.7 million people – 60.6% of the population – have at least one dose of the vaccine. In total, the communities have administered more than 49 million vaccines, after 673,737 applied in the last day, according to the report from the Ministry of Health.

By age group, all those over 80 have the complete guideline; as well as 97.5% of the population between 70 and 79; 75.4% of those between 60 and 69; 84.2% of those between 50 and 59; and 57.1% of citizens between 40 and 49 years old.

Finally, in young people, in the age group between 20 and 29 years old, 12.2% have the complete regimen and 21.6% have at least one dose; 17.7% of those between 30 and 39 have both punctures and 48.7% have at least one, and of those between 12 and 19 years old, 1.1% have finished their immunization and 3 , 7% have the first dose.

Leave a Reply

Your email address will not be published. Required fields are marked *